Medtechs’ View Of UK Brexit Deal: More Certainty, But Still No Detail
COVID-19 is of no lesser importance to the UK medtech industry, but attention is now refocusing on Brexit, future regulation and trade deals.
You may also be interested in...
The UK health care system is keen to reshape in light of the lessons learned from COVID-19, but it comes at a time when Brexit trade issues and device regulatory system changes are already muddying the waters.
Maintaining barrier-free trade with the EU will save time and money, according to the Swiss medtech industry, which has made its views clear in a recent survey run by Swiss Medtech.
BVMed says the EU and the UK should set up a system of mutual recognition of medical device regulation to kick in when the UK’s EU exit transition period ends on 31 December.